168 related articles for article (PubMed ID: 35288649)
1. Inhibition of proinflammatory signaling impairs fibrosis of bone marrow mesenchymal stromal cells in myeloproliferative neoplasms.
Vukotić M; Kapor S; Dragojević T; Đikić D; Mitrović Ajtić O; Diklić M; Subotički T; Živković E; Beleslin Čokić B; Vojvodić A; Santibáñez JF; Gotić M; Čokić VP
Exp Mol Med; 2022 Mar; 54(3):273-284. PubMed ID: 35288649
[TBL] [Abstract][Full Text] [Related]
2. Heterogeneity of the bone marrow niche in patients with myeloproliferative neoplasms: ActivinA secretion by mesenchymal stromal cells correlates with the degree of marrow fibrosis.
Rambaldi B; Diral E; Donsante S; Di Marzo N; Mottadelli F; Cardinale L; Dander E; Isimbaldi G; Pioltelli P; Biondi A; Riminucci M; D'Amico G; Elli EM; Pievani A; Serafini M
Ann Hematol; 2021 Jan; 100(1):105-116. PubMed ID: 33089365
[TBL] [Abstract][Full Text] [Related]
3. Effects of JAK1/2 inhibition on bone marrow stromal cells of myeloproliferative neoplasm (MPN) patients and healthy individuals.
Zacharaki D; Ghazanfari R; Li H; Lim HC; Scheding S
Eur J Haematol; 2018 Jul; 101(1):57-67. PubMed ID: 29645296
[TBL] [Abstract][Full Text] [Related]
4. JAK-STAT signaling mediates the senescence of bone marrow-mesenchymal stem cells from systemic lupus erythematosus patients.
Ji J; Wu Y; Meng Y; Zhang L; Feng G; Xia Y; Xue W; Zhao S; Gu Z; Shao X
Acta Biochim Biophys Sin (Shanghai); 2017 Mar; 49(3):208-215. PubMed ID: 28177455
[TBL] [Abstract][Full Text] [Related]
5. Bone marrow-derived mesenchymal stromal cells promote resistance to tyrosine kinase inhibitors in chronic myeloid leukemia via the IL-7/JAK1/STAT5 pathway.
Zhang X; Tu H; Yang Y; Jiang X; Hu X; Luo Q; Li J
J Biol Chem; 2019 Aug; 294(32):12167-12179. PubMed ID: 31235520
[TBL] [Abstract][Full Text] [Related]
6. Mesenchymal Cell Reprogramming in Experimental MPLW515L Mouse Model of Myelofibrosis.
Han Y; Yue L; Wei M; Ren X; Shao Z; Zhang L; Levine RL; Epling-Burnette PK
PLoS One; 2017; 12(1):e0166014. PubMed ID: 28135282
[TBL] [Abstract][Full Text] [Related]
7. NMDA receptor activation inhibits the antifibrotic effect of BM-MSCs on bleomycin-induced pulmonary fibrosis.
Li X; Li C; Tang Y; Huang Y; Cheng Q; Huang X; Zhao F; Hao C; Feng D; Xu J; Han J; Tang S; Liu W; Yue S; Luo Z
Am J Physiol Lung Cell Mol Physiol; 2018 Sep; 315(3):L404-L421. PubMed ID: 29722562
[TBL] [Abstract][Full Text] [Related]
8. Effects of Bone Marrow-Derived Mesenchymal Stem Cells on Hypoxia and the Transforming Growth Factor beta 1 (TGFβ-1) and SMADs Pathway in a Mouse Model of Cirrhosis.
Zhang L; Zhou D; Li J; Yan X; Zhu J; Xiao P; Chen T; Xie X
Med Sci Monit; 2019 Sep; 25():7182-7190. PubMed ID: 31550244
[TBL] [Abstract][Full Text] [Related]
9. Common and different alterations of bone marrow mesenchymal stromal cells in myelodysplastic syndrome and multiple myeloma.
Choi H; Kim Y; Kang D; Kwon A; Kim J; Min Kim J; Park SS; Kim YJ; Min CK; Kim M
Cell Prolif; 2020 May; 53(5):e12819. PubMed ID: 32372504
[TBL] [Abstract][Full Text] [Related]
10. Adipose tissue-derived multipotent stromal cells have a higher immunomodulatory capacity than their bone marrow-derived counterparts.
Melief SM; Zwaginga JJ; Fibbe WE; Roelofs H
Stem Cells Transl Med; 2013 Jun; 2(6):455-63. PubMed ID: 23694810
[TBL] [Abstract][Full Text] [Related]
11. Bone marrow-derived mesenchymal stem cells promote Helicobacter pylori-associated gastric cancer progression by secreting thrombospondin-2.
Shi H; Qi C; Meng L; Yao H; Jiang C; Fan M; Zhang Q; Hou X; Lin R
Cell Prolif; 2021 Oct; 54(10):e13114. PubMed ID: 34435402
[TBL] [Abstract][Full Text] [Related]
12. Mesenchymal stromal cells in tumor microenvironment remodeling of BCR-ABL negative myeloproliferative diseases.
La Spina E; Giallongo S; Giallongo C; Vicario N; Duminuco A; Parenti R; Giuffrida R; Longhitano L; Li Volti G; Cambria D; Di Raimondo F; Musumeci G; Romano A; Palumbo GA; Tibullo D
Front Oncol; 2023; 13():1141610. PubMed ID: 36910610
[TBL] [Abstract][Full Text] [Related]
13. Microenvironment in neuroblastoma: isolation and characterization of tumor-derived mesenchymal stromal cells.
Pelizzo G; Veschi V; Mantelli M; Croce S; Di Benedetto V; D'Angelo P; Maltese A; Catenacci L; Apuzzo T; Scavo E; Moretta A; Todaro M; Stassi G; Avanzini MA; Calcaterra V
BMC Cancer; 2018 Nov; 18(1):1176. PubMed ID: 30482160
[TBL] [Abstract][Full Text] [Related]
14. Cell-autonomous heparanase modulates self-renewal and migration in bone marrow-derived mesenchymal stem cells.
Cheng CC; Lee YH; Lin SP; Huangfu WC; Liu IH
J Biomed Sci; 2014 Mar; 21(1):21. PubMed ID: 24624965
[TBL] [Abstract][Full Text] [Related]
15. Effect of Function-Enhanced Mesenchymal Stem Cells Infected With Decorin-Expressing Adenovirus on Hepatic Fibrosis.
Jang YO; Cho MY; Yun CO; Baik SK; Park KS; Cha SK; Chang SJ; Kim MY; Lim YL; Kwon SO
Stem Cells Transl Med; 2016 Sep; 5(9):1247-56. PubMed ID: 27365486
[TBL] [Abstract][Full Text] [Related]
16. Mesenchymal stem cells modulate albumin-induced renal tubular inflammation and fibrosis.
Wu HJ; Yiu WH; Li RX; Wong DW; Leung JC; Chan LY; Zhang Y; Lian Q; Lin M; Tse HF; Lai KN; Tang SC
PLoS One; 2014; 9(3):e90883. PubMed ID: 24646687
[TBL] [Abstract][Full Text] [Related]
17. Fibrosis and subsequent cytopenias are associated with basic fibroblast growth factor-deficient pluripotent mesenchymal stromal cells in large granular lymphocyte leukemia.
Mailloux AW; Zhang L; Moscinski L; Bennett JM; Yang L; Yoder SJ; Bloom G; Wei C; Wei S; Sokol L; Loughran TP; Epling-Burnette PK
J Immunol; 2013 Oct; 191(7):3578-93. PubMed ID: 24014875
[TBL] [Abstract][Full Text] [Related]
18. Bone marrow derived-mesenchymal stem cells downregulate IL17A dependent IL6/STAT3 signaling pathway in CCl4-induced rat liver fibrosis.
Farouk S; Sabet S; Abu Zahra FA; El-Ghor AA
PLoS One; 2018; 13(10):e0206130. PubMed ID: 30346985
[TBL] [Abstract][Full Text] [Related]
19. Bone marrow-derived mesenchymal stem/stromal cells in patients with acute myeloid leukemia reveal transcriptome alterations and deficiency in cellular vitality.
Zhang L; Chi Y; Wei Y; Zhang W; Wang F; Zhang L; Zou L; Song B; Zhao X; Han Z
Stem Cell Res Ther; 2021 Jun; 12(1):365. PubMed ID: 34174939
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of hepatic stellate cells by bone marrow-derived mesenchymal stem cells in hepatic fibrosis.
Jang YO; Jun BG; Baik SK; Kim MY; Kwon SO
Clin Mol Hepatol; 2015 Jun; 21(2):141-9. PubMed ID: 26157751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
